Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Eastgate Biotech Corp ETBI

EastGate Biotech Corp. is a biotechnology company. The Company produces and distributes nutraceuticals that are based on natural therapies and absorbed naturally by the body. The Company utilizes nanotechnologies to deliver healthy alternatives to conventional pharmaceuticals that all too often create dangerous side effects and unexpected consequences for those trying to attain and maintain... see more

GREY:ETBI - Post Discussion

Eastgate Biotech Corp > To the moon!
View:
Post by MoMoneyLessProb on Apr 24, 2019 10:59pm

To the moon!

I hope this starts getting the attention it deserves.
Comment by Slowmoe28 on Jun 12, 2019 11:08am
Any day now. This Stock is going to the top.
Comment by MoMoneyLessProb on Oct 26, 2019 3:35am
I cant wait til phase 3 clinical trial results!!!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities